NO995513D0 - N-triazolyl-2-indolecarboxamides and their use as CCK-A agonists - Google Patents

N-triazolyl-2-indolecarboxamides and their use as CCK-A agonists

Info

Publication number
NO995513D0
NO995513D0 NO995513A NO995513A NO995513D0 NO 995513 D0 NO995513 D0 NO 995513D0 NO 995513 A NO995513 A NO 995513A NO 995513 A NO995513 A NO 995513A NO 995513 D0 NO995513 D0 NO 995513D0
Authority
NO
Norway
Prior art keywords
indolecarboxamides
cck
triazolyl
agonists
Prior art date
Application number
NO995513A
Other languages
Norwegian (no)
Other versions
NO995513L (en
Inventor
Eric Bignon
Jean Pierre Bras
Paul De Cointet
Pierre Despeyroux
Daniel Frehel
Danielle Gully
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO995513D0 publication Critical patent/NO995513D0/en
Publication of NO995513L publication Critical patent/NO995513L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
NO995513A 1997-05-13 1999-11-11 N-triazolyl-2-indolecarboxamides and their use as CCK- NO995513L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9705850A FR2763337B1 (en) 1997-05-13 1997-05-13 NOVEL TRIAZOLE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PCT/FR1998/000905 WO1998051686A1 (en) 1997-05-13 1998-05-06 N-triazolyl-2-indolecarboxamides and their use as cck-a agonists

Publications (2)

Publication Number Publication Date
NO995513D0 true NO995513D0 (en) 1999-11-11
NO995513L NO995513L (en) 2000-01-12

Family

ID=9506830

Family Applications (1)

Application Number Title Priority Date Filing Date
NO995513A NO995513L (en) 1997-05-13 1999-11-11 N-triazolyl-2-indolecarboxamides and their use as CCK-

Country Status (35)

Country Link
EP (1) EP0984960B1 (en)
JP (1) JP2001524980A (en)
KR (1) KR20010012541A (en)
CN (1) CN1263528A (en)
AR (1) AR011729A1 (en)
AT (1) ATE232207T1 (en)
AU (1) AU725530B2 (en)
BR (1) BR9811465A (en)
CA (1) CA2289573A1 (en)
CO (1) CO4940485A1 (en)
CZ (1) CZ289484B6 (en)
DE (1) DE69811223T2 (en)
DK (1) DK0984960T3 (en)
DZ (1) DZ2486A1 (en)
EE (1) EE9900524A (en)
ES (1) ES2190081T3 (en)
FR (1) FR2763337B1 (en)
GT (1) GT199800068A (en)
HR (1) HRP980258B1 (en)
HU (1) HUP0002763A3 (en)
ID (1) ID22911A (en)
IL (1) IL132903A0 (en)
IS (1) IS5235A (en)
NO (1) NO995513L (en)
NZ (1) NZ500637A (en)
PL (1) PL336772A1 (en)
RU (1) RU2175323C2 (en)
SI (1) SI0984960T1 (en)
SK (1) SK154299A3 (en)
TR (1) TR199902795T2 (en)
TW (1) TW396155B (en)
UY (1) UY24997A1 (en)
WO (1) WO1998051686A1 (en)
YU (1) YU57999A (en)
ZA (1) ZA983997B (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802530B1 (en) * 1999-12-17 2002-02-22 Sanofi Synthelabo NOVEL BRANCHED SUBSTITUTED AMINO DERIVATIVES OF 3-AMINO-1-PHENYL-1H [1,2,4] TRIAZOLE, METHODS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
FR2815963B1 (en) * 2000-10-26 2003-02-28 Sanofi Synthelabo NOVEL TRIAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PL365328A1 (en) * 2000-10-26 2004-12-27 Sanofi-Synthelabo Triazole derivatives and pharmaceutical compositions comprising them
HUP0004741A2 (en) * 2000-11-28 2002-12-28 Sanofi-Synthelabo Chemical process for the preparation of thiazole derivatives and new intermediate
US20050014805A1 (en) * 2001-10-12 2005-01-20 Chenzhi Zhang Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
EP1314733A1 (en) * 2001-11-22 2003-05-28 Aventis Pharma Deutschland GmbH Indole-2-carboxamides as factor Xa inhibitors
EP1479677A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH New indole derivatives as factor xa inhibitors
EP1532980A1 (en) 2003-11-24 2005-05-25 Novo Nordisk A/S N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
GB0403038D0 (en) * 2004-02-11 2004-03-17 Novartis Ag Organic compounds
JP2010516768A (en) * 2007-01-26 2010-05-20 メルク・シャープ・エンド・ドーム・コーポレイション Substituted aminopyrimidines as cholecystokinin-1 receptor modulators
EP2548618A3 (en) * 2008-07-15 2013-02-27 Novartis AG Heteroaryl derivatives as DGAT1 inhibitors
CN102414207B (en) * 2009-06-09 2015-09-30 埃科特莱茵药品有限公司 Fluorinated aminotriazole derivatives
WO2011048177A1 (en) * 2009-10-22 2011-04-28 Henkel Ag & Co. Kgaa Agent for temporarily styling keratin-containing fibres, containing a non-ionic starch modified by propylene oxide and a chitosane
CN106928147A (en) * 2017-03-14 2017-07-07 华东师范大学 Tricyclic diterpene analog and preparation method thereof and its application in antiprostate cancer is prepared
CN107271623A (en) * 2017-07-27 2017-10-20 青岛啤酒股份有限公司 Beer potableness evaluation method based on human body satiety
WO2021071837A1 (en) 2019-10-07 2021-04-15 Kallyope, Inc. Gpr119 agonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2701708B1 (en) * 1993-02-19 1995-05-19 Sanofi Elf Polysubstituted 2-amido-4-phenylthiazole derivatives, process for their preparation, pharmaceutical composition and use of these derivatives for the preparation of a medicament.
FR2703995B1 (en) * 1993-04-16 1995-07-21 Sanofi Elf 5-ACYLAMINO 1,2,4-THIADIAZOLES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.

Also Published As

Publication number Publication date
TR199902795T2 (en) 2000-02-21
GT199800068A (en) 1999-11-11
YU57999A (en) 2002-06-19
IL132903A0 (en) 2001-03-19
CZ400699A3 (en) 2000-02-16
CN1263528A (en) 2000-08-16
NO995513L (en) 2000-01-12
FR2763337A1 (en) 1998-11-20
DE69811223T2 (en) 2003-11-27
UY24997A1 (en) 2000-10-31
TW396155B (en) 2000-07-01
WO1998051686A1 (en) 1998-11-19
PL336772A1 (en) 2000-07-17
HRP980258B1 (en) 2002-08-31
NZ500637A (en) 2000-11-24
CZ289484B6 (en) 2002-01-16
HUP0002763A2 (en) 2001-06-28
ATE232207T1 (en) 2003-02-15
SK154299A3 (en) 2000-05-16
FR2763337B1 (en) 1999-08-20
JP2001524980A (en) 2001-12-04
DK0984960T3 (en) 2003-05-26
DZ2486A1 (en) 2003-02-01
CO4940485A1 (en) 2000-07-24
ID22911A (en) 1999-12-16
IS5235A (en) 1999-10-29
ES2190081T3 (en) 2003-07-16
AU725530B2 (en) 2000-10-12
EP0984960B1 (en) 2003-02-05
BR9811465A (en) 2000-09-12
EP0984960A1 (en) 2000-03-15
HRP980258A2 (en) 1999-02-28
AU7659998A (en) 1998-12-08
CA2289573A1 (en) 1998-11-19
AR011729A1 (en) 2000-08-30
RU2175323C2 (en) 2001-10-27
DE69811223D1 (en) 2003-03-13
EE9900524A (en) 2000-06-15
HUP0002763A3 (en) 2002-05-28
ZA983997B (en) 1999-11-12
KR20010012541A (en) 2001-02-15
SI0984960T1 (en) 2003-06-30

Similar Documents

Publication Publication Date Title
NO972983D0 (en) Sulfonamides and their use
NO991922L (en) Heteroarlsuccinamides and their use as metalloproteinase inhibitors
NO20001323D0 (en) Dipeptide-apoptosis inhibitors and their use
NO992492D0 (en) Benzamidoaldehydes and their use as cysteine protease inhibitors
DK0958292T3 (en) 4-3 (3-heterocyclyl-1-benzoyl) pyrazoles and their use as herbicides
DK1015434T3 (en) New pyrimidin-4-one and pyrimidin-4-thione as fungicide
DK1133477T3 (en) Substituted benzimidazoles and their use as pair inhibitors
NO20021449L (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use
DK1012137T3 (en) Aromatic C-16-C-20-substituted tetrahydro-prostaglandins and their use as prostaglandin FP agonists
DK1019358T3 (en) 3,3-diarylpropylamines, their use and preparation
DK0832082T3 (en) N-heteroaryl-pyridine sulfonamide derivatives and their use as endothelin antagonists
NO20022334L (en) New composition and application
NO973338D0 (en) N- (4-aryl-thiazol-2-yl) -sulfonamide derivatives and their use
NO20006488D0 (en) Composition and application
NO20003067D0 (en) Antipicornavirus compounds and methods for their use and preparation
DK1073672T3 (en) Antipicornaviral compounds, their preparation and use
DK1112003T3 (en) New composition and application
NO984761D0 (en) Aminoisoquinolines and aminotienopyridine derivatives and their use as anti-inflammatory agents
NO995513D0 (en) N-triazolyl-2-indolecarboxamides and their use as CCK-A agonists
NO994510L (en) Substituted isoquinoline derivatives and their use as anticonvulsants
NO985891D0 (en) Substituted benzamide derivatives and their use as anticonvulsants
DK1214302T3 (en) Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones and their use as lipase inhibitors
NO20013085D0 (en) Phosphorus-organic compounds and their use
NO20003142D0 (en) Substituted isoquinoline derivatives and their use as anticonvulsants
NO972256D0 (en) O-Benzyloximeter derivatives and their use as pesticides

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application